Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.
暂无分享,去创建一个
Y. Liaw | J. Kao | Yi‐Hsiang Huang | R. Chien | W. Su | Chuan‐Mo Lee | C. Peng | W. Chuang | Chao-Wei Hsu | H. Chu